• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Cross-Border Impact Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    OXcan raises £9m Series A led by We Venture Capital and Cross-Border Impact Ventures to revolutionise early lung cancer detectionOXcan raises £9m Series A led by We Venture Capital and Cross-Border Impact Ventures to revolutionise early lung cancer detection
    OXcan
    9 Jan 2025

    OXcan raises £9m Series A led by We Venture Capital and Cross-Border Impact Ventures to revolutionise early lung cancer detection

    OXcan develops blood-based liquid biopsy tests using proteomics and AI to detect lung cancer at earlier stages, enabling minimally invasive screening designed to improve outcomes and reduce pressure on healthcare systems.

Cross-Border Impact Ventures
    • Life Sciences
  • crossborder.ventures
  • Update Information

More venture news

  • Cerca Magnetics raises £3.8m Series A led by Guinness Ventures for wearable quantum brain scanner
    Cerca Magnetics
    21 Apr 2026

    Cerca Magnetics raises £3.8m Series A led by Guinness Ventures for wearable quantum brain scanner

    Series AHealth
  • Gizmo raises £16m Series A led by Shine Capital to help students study with interactive AI platform
    Gizmo
    15 Apr 2026

    Gizmo raises £16m Series A led by Shine Capital to help students study with interactive AI platform

    Series AEducation
  • TraqCheck raises £6m Series A led by IvyCap Ventures for HR recruitment and screening software
    TraqCheck
    15 Apr 2026

    TraqCheck raises £6m Series A led by IvyCap Ventures for HR recruitment and screening software

    Series AEnterprise

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn